Status | Study |
Recruiting |
Study Name: Effect of Remote Ischaemic Conditioning in Oncology Patients Condition: Cardiotoxicity Date: 2015-05-05 Interventions: Procedure: Remote Ischaemic Conditioning |
Recruiting |
Study Name: Diffusion Weighted Imaging as a Biomarker for Detection of Chemotherapy Induced Cardiotoxicity Condition: Chemotherapy Induced Cardiotoxicity in Breast Cancer Patients Date: 2014-10-22 Interventions: Device: cardiac MRI with DWI |
Recruiting |
Study Name: Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab Condition: Breast Cancer Cardiotoxicity Date: 2014-09-09 Interventions: Drug: Bisoprolol 5 mg daily |
Recruiting |
Study Name: PhysioFlow to Detect Cardiotoxicity in Chemo Condition: Chemotherapy, Cancer, Cardiotoxicity, Physioflow Date: 2014-08-14 |
Recruiting |
Study Name: Cardiotoxicity in Metastatic Her 2 Positive Patients Treated With Trastuzumab ,Pertuzumab and Taxanes Condition: Cardiotoxicity. Anti Her2 Therapy. Date: 2014-03-05 |
Completed |
Study Name: Spironolactone Against Anthracycline-induced Cardiomyopathy Condition: Anthracycline Induced Cardiotoxicity Date: 2014-01-30 Interventions: Drug: Spironolactone Spironola |
Completed |
Study Name: Early Detection of Broken Hearts in Cancer Patients Condition: Cardiotoxicity Date: 2013-10-16 |
Active, not recruiting |
Study Name: Preventing Cardiac Sequelae in Pediatric Cancer Survivors Condition: Anthracycline-induced Cardiotoxicity Date: 2013-02-28 |
Recruiting |
Study Name: Carvedilol Effect in Preventing Chemotherapy - Induced Cardiotoxicity Condition: Breast Cancer Heart Failure Cardioto Date: 2012-06-11 Interventions: Drug: Carvedilol 50mg/day for |
Completed |
Study Name: Usefulness of Myocardial Deformation Imaging for Trastuzumab-induced Cardiotoxicity Condition: Left Ventricular Function Systolic Dysfunction Cardiotoxicity Date: 2011-12-13 |